RCEL

Avita Medical (RCEL)

About Avita Medical (RCEL)

AVITA Medical, Inc., through its subsidiaries, engages in the development and commercialization of a technology platform that enables point-of-care autologous skin restoration for multiple unmet needs. Its product, RECELL system, is a device that enables healthcare professionals to produce a suspension of spray-on skin cells using a small sample of the patient's own skin for the treatment of acute thermal burns. The company was founded in December 1992 and is headquartered in Valencia, CA.

Details

Daily high
$9.18
Daily low
$8.86
Price at open
$9.18
52 Week High
$16.65
52 Week Low
$7.51
Market cap
222.6M
Dividend yield
0.00%
Volume
249,780
Avg. volume
214,648
P/E ratio
-3.75

Avita Medical News

Details

Daily high
$9.18
Daily low
$8.86
Price at open
$9.18
52 Week High
$16.65
52 Week Low
$7.51
Market cap
222.6M
Dividend yield
0.00%
Volume
249,780
Avg. volume
214,648
P/E ratio
-3.75